Group 1 - Lumexa Imaging Holdings (LMRI.US) has submitted an IPO application to the SEC, aiming to raise up to $200 million [1][2] - The company operates 184 diagnostic imaging centers across 13 states, providing advanced and routine imaging services including MRI, CT, PET, X-ray, ultrasound, and mammography [1] - Lumexa Imaging was founded in 2018 by Charlotte Radiology and Welsh, Carson, Anderson & Stowe, starting with 20 centers and expanding through 20 acquisitions and the opening of 41 new locations [1] Group 2 - The company achieved revenue of $1 billion for the 12 months ending September 30, 2025, and plans to list on the NASDAQ under the ticker symbol LMRI [2] - The IPO's joint bookrunners include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James, and PNC Capital Markets [2] - The pricing terms for the offering have not yet been disclosed [2]
诊断影像服务提供商Lumexa Imaging Holdings(LMRI.US)申请在美IPO 拟募资约2亿美元
智通财经网·2025-11-18 07:04